$0.72
0.02[2.86%]
Last update: 9:56AM Get Real Time Here
Alzamend Neuro
(NASDAQ:ALZN)Alzamend Neuro Stock (NASDAQ:ALZN), Analyst Ratings, Price Targets, Predictions
Alzamend Neuro Inc has a consensus price target of $4.75, established from looking at the 2 latest analyst ratings. The last 2 analyst ratings were released from Maxim Group and Ascendiant Capital on April 12, 2023 and October 1, 2021. With an average price target of $4.75 between Maxim Group and Ascendiant Capital, there's an implied 550.68% upside for Alzamend Neuro Inc from these 2 analyst ratings.
Analyst Firms Making Recommendations1
Maxim Group
Ascendiant Capital
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Alzamend Neuro
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/12/2023 | ALZN | Buy Now | Alzamend Neuro | $0.73 | 105.48% | Maxim Group | Michael Okunewitch | → $22.5 | Initiates | → Buy | Get Alert |
| 10/01/2021 | ALZN | Buy Now | Alzamend Neuro | $0.73 | 995.89% | Ascendiant Capital | Edward Woo | → $120 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Alzamend Neuro (ALZN)?
The latest price target for Alzamend Neuro (NASDAQ: ALZN) was reported by Maxim Group on April 12, 2023. The analyst firm set a price target for $1.50 expecting ALZN to rise to within 12 months (a possible 108.33% upside). 0 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Alzamend Neuro (ALZN)?
The latest analyst rating for Alzamend Neuro (NASDAQ: ALZN) was provided by Maxim Group, and Alzamend Neuro initiated their buy rating.
When was the last upgrade for Alzamend Neuro (ALZN)?
There is no last upgrade for Alzamend Neuro.
When was the last downgrade for Alzamend Neuro (ALZN)?
There is no last downgrade for Alzamend Neuro.
When is the next analyst rating going to be posted or updated for Alzamend Neuro (ALZN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alzamend Neuro, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alzamend Neuro was filed on April 12, 2023 so you should expect the next rating to be made available sometime around April 12, 2024.
Is the Analyst Rating Alzamend Neuro (ALZN) correct?
While ratings are subjective and will change, the latest Alzamend Neuro (ALZN) rating was a initiated with a price target of $0.00 to $1.50. The current price Alzamend Neuro (ALZN) is trading at is $0.72, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.